Dilaudid (hydromorphone) is roughly five times stronger than morphine on a milligram-for-milligram basis. That makes it one of the more potent opioid painkillers prescribed in clinical settings, reserved for moderate-to-severe pain that hasn’t responded to other treatments.
How Dilaudid Compares to Other Opioids
The standard way to measure opioid strength is by comparing everything to morphine. Using that scale, hydromorphone has a relative potency of 4 to 5, meaning it takes only about 5 mg of oral hydromorphone to match 25 mg of oral morphine. Through an IV, the ratio holds: 2 mg of hydromorphone equals roughly 10 mg of morphine.
To put that in broader context, here’s how several common opioids stack up against morphine:
- Codeine: weaker than morphine
- Hydrocodone (Vicodin): roughly equal to morphine
- Oxycodone (OxyContin, Percocet): about 1.5 times stronger than morphine
- Hydromorphone (Dilaudid): 4 to 5 times stronger than morphine
- Fentanyl: about 100 times stronger than morphine
So Dilaudid sits in the upper range of commonly prescribed opioids but well below fentanyl. It’s significantly stronger than oxycodone and several tiers above hydrocodone or codeine.
Why Dilaudid Is So Potent
All opioids work by binding to the same type of receptor in the brain and spinal cord, triggering pain relief, sedation, and (at higher doses) slowed breathing. What separates one opioid from another is how tightly each molecule grips that receptor.
Hydromorphone belongs to a small group of opioids with exceptionally strong receptor binding. Lab measurements place it in the highest-affinity category alongside oxymorphone, sufentanil, and buprenorphine. Drugs like codeine, tramadol, and even oxycodone bind far less tightly. That tight binding is what allows a small dose of Dilaudid to produce the same level of pain relief as a much larger dose of a weaker opioid.
When Dilaudid Is Prescribed
Because of its potency and abuse potential, hydromorphone is not a first-line painkiller. It’s prescribed only after milder options, including non-opioid pain relievers and weaker opioids, have failed or aren’t tolerated. Common scenarios include severe post-surgical pain, cancer-related pain, and pain management in ICU patients who need reliable sedation.
The high-potency injectable form is restricted even further. It’s intended only for patients who are already opioid-tolerant, meaning their bodies have adapted to regular opioid use and they need higher doses to achieve pain control. Giving that formulation to someone without opioid tolerance can be dangerous.
How Quickly It Works and How Long It Lasts
Oral hydromorphone typically begins working within 15 to 30 minutes, with peak effects arriving around 30 to 60 minutes. Pain relief generally lasts 4 to 6 hours per dose. The IV form acts faster, often within 5 minutes, but wears off on a similar timeline. This relatively short duration is one reason it’s sometimes preferred in hospital settings: clinicians can adjust dosing more quickly than with longer-acting opioids like methadone.
How the Body Processes It
After you take Dilaudid orally, about 62% of it is broken down by the liver before it ever reaches your bloodstream. The liver converts it primarily into a byproduct called H3G, which has no painkilling effect and is cleared through the kidneys.
This matters most for people with kidney problems. While hydromorphone itself doesn’t tend to accumulate in the body, that H3G byproduct can build up when the kidneys aren’t filtering well. In patients with significantly reduced kidney function, this buildup has been linked to muscle jerking, confusion, and agitation. People on dialysis may also notice that pain relief seems shorter between sessions as the metabolite accumulates.
Respiratory Depression and Overdose Risk
The most dangerous effect of any opioid is slowed breathing, and Dilaudid’s high potency means the margin for error is smaller. A dose that’s therapeutic for one person can suppress breathing in someone with less opioid tolerance.
In a study of prescription opioid overdoses treated by emergency responders, about 44% of hydromorphone cases involved severe respiratory depression, a rate comparable to morphine (42%) and higher than oxycodone (32%) or hydrocodone (29%). Fentanyl had the highest rate at 83%. The physical signs that signal a dangerous overdose include breathing that drops below 12 breaths per minute, blood oxygen levels falling below 90%, and a significant drop in blood pressure.
The risk climbs when hydromorphone is combined with other sedating substances: alcohol, benzodiazepines (like Xanax or Valium), sleep medications, or muscle relaxants. Each of these independently slows breathing, and the combination can be lethal even at doses that would be survivable on their own.
Why the Potency Matters Practically
Dilaudid’s strength means that even small errors in dosing carry outsized consequences. A person switching from a weaker opioid might not realize that a “small” tablet of hydromorphone delivers several times more effect per milligram than what they were taking before. This is one of the reasons dose conversions between opioids are done carefully, often using conservative ratios to avoid accidental overdose during the switch.
For the same reason, hydromorphone carries a high potential for misuse. Its strong receptor binding produces intense euphoria at higher doses, which contributes to its classification as a Schedule II controlled substance, the most tightly regulated category for drugs that still have accepted medical use.